Paolo Regi
Paolo Regi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Giardino
Hepato-pancreato-biliary Surgery Department, Pederzoli Hospital, Peschiera Del Garda, Italy
1 shared publication - Chiara Calabrese
Department of Medicine and Aging Sciences, Section of Biomorphology, “G. d’Annunzio” University of Chieti-Pescara, Via dei Vestini, 31, 66100 Chieti, Italy
1 shared publication - Clara Cena
Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy
1 shared publication - Claudio Bassi
Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy
1 shared publication - Emanuela Guerra
Dipartimento di Biotecnologie Agrarie ed Ambientali, Università degli studi di Ancona, Via Brecce Bianche, 60100 Ancona, Italy
1 shared publication - Filippo Maria Martelli
Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37134 Verona, Italy
1 shared publication
Latest Publications
- Open Access
- 13 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4313
Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report
Pancreatic cancer, most frequently as ductal adenocarcinoma (PDAC), is the third leading cause of cancer death. Clear-cell primary adenocarcinoma of the pancreas (CCCP) is a rare, aggressive, still poorly characterized subtype of PDAC. We report here a case of a 65-year-old male presenting with pancreatic neoplasia. A histochemical examination of the tumor showed large cells with clear and abundant intracytoplasmic vacuoles. The clear-cell foamy appearance was not related to the hyperproduction of mucins. Ultrastructural characterization with transmission electron microscopy revealed the massive presence of mitochondria in the clear-cell cytoplasm. The mitochondria showed disordered cristae and various degrees of loss of structural integrity. Immunohistochemistry staining for NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2 (NDUFA4L2) proved specifically negative for the clear-cell tumor. Our ultrastructural and molecular data indicate that the clear-cell nature in CCCP is linked to the accumulation of disrupted mitochondria. We propose that this may impact on the origin and progression of this PDAC subtype.
- 13 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4313
Open AccessNovel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report
Pancreatic cancer, most frequently as ductal adenocarcinoma (PDAC), is the third leading cause of cancer death. Clear-cell primary adenocarcinoma of the pancreas (CCCP) is a rare, aggressive, still poorly characterized subtype of PDAC. We report here a case of a 65-year-old male presenting with pancreatic neoplasia. A histochemical examination of the tumor showed large cells with clear and abundant intracytoplasmic vacuoles. The clear-cell foamy appearance was not related to the hyperproduction of mucins. Ultrastructural characterization with transmission electron microscopy revealed the massive presence of mitochondria in the clear-cell cytoplasm. The mitochondria showed disordered cristae and various degrees of loss of structural integrity. Immunohistochemistry staining for NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2 (NDUFA4L2) proved specifically negative for the clear-cell tumor. Our ultrastructural and molecular data indicate that the clear-cell nature in CCCP is linked to the accumulation of disrupted mitochondria. We propose that this may impact on the origin and progression of this PDAC subtype.
- 21 February 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (3) , 266-274
Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma
- 21 February 2023
- Published by Elsevier in Pancreatology
- Vol. 23 (3) , 266-274
Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma
- 27 December 2012
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 11 (2) , 157-160
Cystic “feminine” pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities?
Introduction: Mucinous cystic neoplasm (MCN) and solid pseudopapillary neoplasm (SPN) of the pancreas are uncommon hormone-related pancreatic tumors (HRPTs) with a clear predominance in young women. This trial aims to investigate the possible association between HRPTs development in males and phenotypic and sex hormone alterations. Methods: We performed a retrospective analysis of our database between February 1990 and February 2012. Risk factors for sexual dysfunction were considered exclusion criteria. We investigated secondary sexual characteristics development, sex hormone level and overall sexual dysfunction degree according with the International Index of Erectile Function Questionnaire (IIEF). Results: We initially identified 25 patients [(MCN: n = 16 (64%); SPN: n = 9 (36%)]. At follow-up, 5 patients were lost, 8 resulted dead and 3 were excluded according to exclusion criteria. We finally enrolled 9 patients (MCN: n = 5; SPN: n = 4). Puberty occurred within physiological age for 7 patients, whereas it was delayed in 2 cases. Three patients revealed mild to moderate sexual dysfunction, along with low testosterone level in two cases. One patient presented hormonal alteration with a normal IIEF score. Discussion: In this study, the first in literature with similar aim, hormonal and/or sexual dysfunction was present in 4 out of 9 patients affected by HRPT. The rarity of these lesions makes further trials to be needed for reliable conclusions.
- 27 December 2012
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 11 (2) , 157-160
Cystic “feminine” pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities?
Introduction: Mucinous cystic neoplasm (MCN) and solid pseudopapillary neoplasm (SPN) of the pancreas are uncommon hormone-related pancreatic tumors (HRPTs) with a clear predominance in young women. This trial aims to investigate the possible association between HRPTs development in males and phenotypic and sex hormone alterations. Methods: We performed a retrospective analysis of our database between February 1990 and February 2012. Risk factors for sexual dysfunction were considered exclusion criteria. We investigated secondary sexual characteristics development, sex hormone level and overall sexual dysfunction degree according with the International Index of Erectile Function Questionnaire (IIEF). Results: We initially identified 25 patients [(MCN: n = 16 (64%); SPN: n = 9 (36%)]. At follow-up, 5 patients were lost, 8 resulted dead and 3 were excluded according to exclusion criteria. We finally enrolled 9 patients (MCN: n = 5; SPN: n = 4). Puberty occurred within physiological age for 7 patients, whereas it was delayed in 2 cases. Three patients revealed mild to moderate sexual dysfunction, along with low testosterone level in two cases. One patient presented hormonal alteration with a normal IIEF score. Discussion: In this study, the first in literature with similar aim, hormonal and/or sexual dysfunction was present in 4 out of 9 patients affected by HRPT. The rarity of these lesions makes further trials to be needed for reliable conclusions.